Albemarle (ALB) Prices 8.5M Share Common Offering at $153/Sh

Pre-Open Stock Movers 02/03: (TYME) (GWPH) (GOOGL) Higher; (VXRT) (VYGR) (TENB) Lower (more...)

Pre-Open Stock Movers:

Tyme Technologies, Inc. (NASDAQ: TYME) 60% HIGHER; announced that it has received notification that the United States Patent and Trademark Office has granted additional patent claims related to the Companys metabolomic technology platform. The patent, U.S. Patent No. 10,905,698, is directed to methods for treating COVID-19.

Vaxart, Inc., (NASDAQ: VXRT) 53.2% LOWR; announced preliminary data from its Phase 1 study of VXA-CoV2-1... More

After-Hours Stock Movers 02/02: (CLIR) (ARAY) (GOOGL) Higher; (VYGR) (PED) (MTCH) Lower (more...)

After-Hours Stock Movers

ClearSign Technologies Corporation (Nasdaq: CLIR) 13.9% HIGHER; has received a purchase order from a global refining company to design, fabricate and supply the Company's ClearSign Core process burner for installation in a European refinery. This is the first purchase from this customer and the second super major customer for the Company.

Voyager Therapeutics, Inc. (Nasdaq: VYGR) 11.3% LOWER; announced that Neurocrine Biosciences, Inc. (Nasdaq: NBIX) provided notice of termination of the... More

Albemarle shares slip on $1.3 billion stock offering

(Reuters) - Albemarle Corp shares slipped 1.5% in extended trading on Tuesday after the world's largest producer of lithium launched a $1.3 billion share offering to fund its growth plans and pay down debt.

The company last month said it expects demand for the white metal used in electric vehicle (EV)... More

Albemarle (ALB) Reports Prelim. Q4 Results

Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, today announced preliminary results for the fourth quarter ended December 31, 2020.

Fourth-Quarter 2020 Highlights(Unless otherwise stated, all percent changes are based on year-over-year comparisons)

Albemarle (ALB) to Offer $1.3B in Common Stock

Albemarle Corporation (NYSE: ALB) announced that it has commenced an underwritten public offering of $1,300,000,000 of shares of its common stock. In connection with this offering, Albemarle expects to grant the underwriters a 30-day option to purchase up to $195,000,000 of additional shares at the public... More